Campbell v. Boston Scientific Corp., No. 16-2279 (4th Cir. 2018)Annotate this Case
In these consolidated products liability cases involving a transvaginal mesh prescription device called Obtryx, the jury returned verdicts for plaintiffs, awarding over $4 million to each. The Fourth Circuit held that the district court did not abuse its discretion in consolidating the four cases where common questions of fact and law formed a substantial part of each suit and the district court bent over backwards to ensure that distinct questions of fact and law could be appropriately developed at trial and distinguished by the jury. The court rejected BSC's evidentiary challenges; BSC was not entitled to judgment as a matter of law where it failed to establish that there was insufficient evidence to defeat the jury awards; and the district court's instruction to the jury regarding punitive damages was a correct statement of West Virginia law at the time of the trial. Accordingly, the court affirmed the district court's judgments.